We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Xaar Plc | XAR | London | Ordinary Share |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
80.20 | 80.20 | 80.20 | 80.20 |
Industry Sector |
---|
TECHNOLOGY HARDWARE & EQUIPMENT |
Top Posts |
---|
Posted at 23/1/2024 12:56 by scarboro OIT useful update re XAR 180124 |
Posted at 12/1/2024 10:07 by darrin1471 Short term is still:"The Board anticipates that weaker demand during Q4 2023 will continue into 2024, and together with delays in some customer product launches, will result in lower revenue and adjusted profit in 2024 than previously anticipated. We are optimistic and remain focused on delivering significant opportunities in our customer pipeline. -- In 2024 the Group also faces the full effect of increased input costs. The lower than previously expected revenue growth in 2024 will not be sufficient to fully absorb the additional costs, which will impact Gross Margin." XAR was priced for better so any more setbacks will hurt. Risk/reward does not look good at the moment. |
Posted at 02/12/2023 11:32 by darrin1471 If there had not been better opportunities elsewhere, I would of probably of bought below 170 for a 20% bounce or for a multi year holding.This weeks trading update is a shocking turn around in the 2024 prospects. Progressive research have cut their 2024 full year PBT from 4.2m to 0.4m. It's a must read for any small investor or anybody looking at XAAR: With little prospect of a turn around in outlook for 6 months, then some holders are likely to sell and who is going to buy at the current price. XAAR may become a target of short sellers given its high valuation. I still like the medium/long term XAAR story but now expect to see a better entry point in the future. I hold no long or short position in XAR |
Posted at 29/11/2023 08:14 by napoleon 14th Sold remainder of reduced stake.IMO management are good & rescued XAR, but new products haven't sold as well as hoped. P/E ratio extravagant for a business that finds headway so tough and disappoints. Paid 74.5p in July 2020, so WTF?! |
Posted at 13/3/2023 14:22 by gargoyle2 Tipped in SCSW at the weekend -- 'I think XAR is set to become a big BUY in the latter part of the year but looking at its history, it could easily surprise positively sooner.' |
Posted at 25/1/2023 13:03 by napoleon 14th Up 100%+ after 2.5 years in XAR, but greed and realism tell me to keep until £5. |
Posted at 24/7/2022 12:23 by brucie5 Well, yes and no. A stonkingly high PE can also be evidence of an overvalued share price.It really depends on growth in those earnings, hence Slater's interest in PEG ratio. But the case for XAR, I believe, having listened to CR, is its reinvention on basis of its IP larder, and potential demand for its new aquieous ink product, with enhanced ESG. |
Posted at 28/4/2022 09:05 by tomps2 XAR pitched in the latest episode of Sell It To The CityRichard Crow pitches Xaar (XAR) to leading fund managers, Andy Brough, Judith MacKenzie and Stephen English at 2m20s in the latest PIWORLD Sell It To The city. Watch the video here: www.piworld.co.uk/ed Or listen to the podcast here: piworld.podbean.com/ |
Posted at 09/4/2022 20:24 by grahamnash Anyone know where I can find predicted forward figures for XAR: profit;PE;PEG;debt and so on? TIA. |
Posted at 29/3/2022 07:19 by ny boy Solid management, been holding and adding over the last year, starting to show healthy returns, it’s a XAR thang! Strong hold imo |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions